We compared the levels of B3GNT5 mRNA expression in normal human astrocytes (NHAs), glioma cell lines (A172, A1207, U87MG, and LN229), and patient‐derived GSCs (GSC11, 20, 23, and 267) (Figure 2A). This evidence concerns the gene B3GNT5 and glioma.